CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,895,524 | -23.3% | 142,980 | -37.3% | 0.02% | -25.0% |
| Q2 2023 | $5,076,649 | +3.0% | 228,167 | +0.3% | 0.02% | -9.1% |
| Q1 2023 | $4,928,646 | +1197.6% | 227,546 | +1116.7% | 0.02% | +1000.0% |
| Q4 2022 | $379,838 | -20.2% | 18,702 | +0.8% | 0.00% | -33.3% |
| Q3 2022 | $476,000 | +163.0% | 18,555 | +143.1% | 0.00% | +200.0% |
| Q2 2022 | $181,000 | +18.3% | 7,632 | +12.2% | 0.00% | 0.0% |
| Q1 2022 | $153,000 | +112.5% | 6,805 | +87.8% | 0.00% | – |
| Q4 2021 | $72,000 | +9.1% | 3,624 | +7.6% | 0.00% | -100.0% |
| Q3 2021 | $66,000 | -9.6% | 3,368 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $73,000 | -23.2% | 3,331 | -16.2% | 0.00% | 0.0% |
| Q1 2021 | $95,000 | +1483.3% | 3,975 | +1706.8% | 0.00% | – |
| Q4 2020 | $6,000 | +200.0% | 220 | +83.3% | 0.00% | – |
| Q3 2020 | $2,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |